Concepedia

Institution (Healthcare)

Taustine Eye Center

HomepageROR

Also Known As

Taustine Eye Center

27

Publications

791

Citations

2

Authors

9

Concepts

About

Taustine Eye Center is a healthcare institution in Louisville, United States known for medicine, glaucoma, and ophthalmology.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

5

5

409

2

Pharmacology

2

2

270

3

Hypertension

2

2

183

4

Clinical Trials

1

1

140

5

Physiology

1

1

130

Taustine Eye Center

×

27

Publications

791

Citations

YearCitations

A randomized trial in patients inadequately controlled with timolol alone comparing the dorzolamide-timolol combination to monotherapy with timolol or dorzolamide 11Ms. Clineschmidt, Dr. Adamsons, Dr. Snyder, and Dr. Reines are employees of Merck & Co., Inc., the manufacturer of the dorzolamide-timolol combination. The other authors have no proprietary interest in the dorzolamide-timolol combination or in Merck.

Coleen M. Clineschmidt, Robert Williams, Ellen Snyder,

Ophthalmology

1998

140

Ocular Hypotensive Effect of the Rho Kinase Inhibitor AR-12286 in Patients With Glaucoma and Ocular Hypertension

Robert D. Williams, Gary D. Novack, Thomas van Haarlem,

American Journal of Ophthalmology

2011

130

Brimonidine and Timolol Fixed-Combination Therapy Versus Monotherapy: A 3-Month Randomized Trial in Patients with Glaucoma or Ocular Hypertension

E. Randy Craven, Thomas R. Walters, Robert D. Williams,

Journal of Ocular Pharmacology and Therapeutics

2005

79

Efficacy of bimatoprost in glaucoma and ocular hypertension unresponsive to latanoprost

Robert D. Williams

Advances in Therapy

2002

53

Long-term efficacy and safety of bimatoprost for intraocular pressure lowering in glaucoma and ocular hypertension: year 4

Robert D. Williams, John Cohen, Ronald L. Gross,

British Journal of Ophthalmology

2008

51

Increased periocular pigmentation with ocular hypotensive lipid use in African Americans

Leon W. Herndon, Robert D. Williams, Martin Wand,

American Journal of Ophthalmology

2003

47

Lotilaner Ophthalmic Solution 0.25% for Demodex Blepharitis

Ian Benjamin Gaddie, Eric D. Donnenfeld, Paul Karpecki,

Ophthalmology

2023

43

A 3-month clinical trial comparing the IOP-lowering efficacy of bimatoprost and latanoprost in patients with normal-tension glaucoma

Monte S. Dirks, Robert J. Noecker, Melissa Earl,

Advances in Therapy

2006

39

Clinical diagnosis and management of Demodex blepharitis: the Demodex Expert Panel on Treatment and Eyelid Health (DEPTH)

Brandon D. Ayres, Eric D. Donnenfeld, Marjan Farid,

Eye

2023

35

Evaluation of a new artificial tear formulation for the management of tear film stability and visual function in patients with dry eye

Gail Torkildsen, Mile Brujic, M Cooper,

Clinical ophthalmology

2017

19

Page 1